Position in ABBV
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$967,807
+$111,984 QoQ
Shares Held
3,846
-2.3% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.20%
of 13F equity value
Holder Rank
#2,575
of 4,153 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026M. Kulyk & Associates, LLC holds $37,765,981 across 8 Drug Manufacturers - General names. ABBV ranks #5 (2.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
94,863 | $12,189,895 | |
| 2 | LLY |
ELI LILLY & Co
|
7,945 | $9,529,472 | |
| 3 | GILD |
Gilead Sciences, Inc.
|
74,859 | $9,457,686 | |
| 4 | NVO |
Novo Nordisk A S
|
93,400 | $4,477,596 | |
| 5 | ABBV |
AbbVie Inc.
This page
|
3,846 | $967,807 | |
| 6 | JNJ |
Johnson & Johnson
|
1,941 | $492,955 | |
| 7 | NVS |
Novartis AG
|
2,439 | $382,240 | |
| 8 | AMGN |
Amgen Inc
|
741 | $268,330 |
All Filings in ABBV
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $967,807 | 3,846 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $855,823 | 3,935 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $896,137 | 3,922 | Shares | Sole | 2026-01-08 | |
| 2025-09-30 | $910,878 | 3,934 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $705,727 | 3,802 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $845,203 | 4,034 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $711,510 | 4,004 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $958,962 | 4,856 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $811,118 | 4,729 | Shares | Sole | 2024-08-05 | |
| 2024-03-31 | $861,150 | 4,729 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $752,224 | 4,854 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $723,537 | 4,854 | Shares | Sole | 2023-11-07 | |
| 2023-06-30 | $682,542 | 5,066 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $813,265 | 5,103 | Shares | Sole | 2023-05-08 | |
| 2022-12-31 | $831,806 | 5,147 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $680,713 | 5,072 | Shares | Sole | 2022-11-07 | |
| 2022-06-30 | $776,827 | 5,072 | Shares | Sole | 2022-08-05 | |
| 2022-03-31 | $893,874 | 5,514 | Shares | Sole | 2022-05-11 | |
| 2021-12-31 | $706,652 | 5,219 | Shares | Sole | 2022-01-20 | |
| 2021-09-30 | $257,269 | 2,385 | Shares | Sole | 2021-10-21 | |
| 2021-06-30 | $251,750 | 2,235 | Shares | Sole | 2021-07-21 | |
| 2021-03-31 | $242,953 | 2,245 | Shares | Sole | 2021-04-29 | |
| No filing history on record for this holder in this stock. | ||||||